Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Barry Uretsky to Cardiovascular Agents

This is a "connection" page, showing publications Barry Uretsky has written about Cardiovascular Agents.

 
Connection Strength
  
 
 
0.901
  
  1. Uretsky BF. Treating the left main bifurcation lesion: the "three stent solution". Catheter Cardiovasc Interv. 2009 Jan 01; 73(1):42-3.
    View in: PubMed
    Score: 0.327
  2. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004 Oct 06; 44(7):1343-53.
    View in: PubMed
    Score: 0.244
  3. Osman A, Otero J, Brizolara A, Waxman S, Stouffer G, Fitzgerald P, Uretsky BF. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Am Heart J. 2004 May; 147(5):e23.
    View in: PubMed
    Score: 0.237
  4. Merla R, Daher IN, Ye Y, Uretsky BF, Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J. 2007 Aug; 154(2):391-402.
    View in: PubMed
    Score: 0.074
  5. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv. 2008 Apr 01; 71(5):636-43.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.